Swissmedic reviews vaccine candidate from Moderna
Bern, 13.11.2020 - Another COVID-19 vaccine under rolling review The biotech company Moderna has submitted an application to Swissmedic, the Swiss Agency for Therapeutic Products, for the authorisation of its vaccine candidate mRNA-1273. This is the third authorisation procedure initiated in Switzerland for a vaccine against the novel coronavirus.